Literature DB >> 18935927

Management of locally advanced or unresectable head and neck cancer.

Bruce Culliney1, Aminu Birhan, Amy V Young, Walter Choi, Maxim Shulimovich, Ronald H Blum.   

Abstract

The treatment of patients with locoregionally advanced or unresectable squamous cell carcinoma of the head and neck is complex and associated with significant toxicities. During the past 30 years, there has been an ongoing shift in what is perceived as the best treatment approach. Differing radiation techniques have been employed, and chemotherapy has been incorporated in both sequential and concomitant strategies. In this article, we will review the available data regarding many of the advances that have been achieved. We will also discuss the most relevant recent clinical trials, as well as ongoing trials that will hopefully answer some of the questions that remain as we attempt to best treat this patient population

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18935927

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  7 in total

1.  Gain-of-function mutant p53 but not p53 deletion promotes head and neck cancer progression in response to oncogenic K-ras.

Authors:  Sergio Acin; Zhongyou Li; Olga Mejia; Dennis R Roop; Adel K El-Naggar; Carlos Caulin
Journal:  J Pathol       Date:  2011-09-26       Impact factor: 7.996

2.  Withaferin A, a cytotoxic steroid from Vassobia breviflora, induces apoptosis in human head and neck squamous cell carcinoma.

Authors:  Abbas K Samadi; Xiaoqin Tong; Ridhwi Mukerji; Huaping Zhang; Barbara N Timmermann; Mark S Cohen
Journal:  J Nat Prod       Date:  2010-09-24       Impact factor: 4.050

3.  Tubulin α-6 chain is a stably expressed reference gene in archival samples of normal oral tissue and oral squamous cell carcinoma.

Authors:  Matilda Rentoft; Sara Hultin; Philip John Coates; Göran Laurell; Karin Nylander
Journal:  Exp Ther Med       Date:  2010-05-01       Impact factor: 2.447

4.  Establishment and characterization of a novel head and neck squamous cell carcinoma cell line USC-HN1.

Authors:  Daniel J Liebertz; Melissa G Lechner; Rizwan Masood; Uttam K Sinha; Jing Han; Raj K Puri; Adrian J Correa; Alan L Epstein
Journal:  Head Neck Oncol       Date:  2010-02-22

5.  A novel dual signaling axis for NSP 5a3a induced apoptosis in head and neck carcinoma.

Authors:  Luca D'Agostino; Antonio Giordano
Journal:  Oncotarget       Date:  2011-12

6.  The role of induction chemotherapy followed by surgery in unresectable stage IVb laryngeal and hypopharyngeal cancers: a case series.

Authors:  Pichit Sittitrai; Donyarat Reunmarkkaew; Saisaward Chaiyasate
Journal:  J Otolaryngol Head Neck Surg       Date:  2018-10-16

Review 7.  New Challenges of Treatment for Locally Advanced Head and Neck Cancers in the Covid-19 Pandemic Era.

Authors:  Camil Ciprian Mireștean; Anda Crișan; Adina Mitrea; Călin Buzea; Roxana Irina Iancu; Dragoș Petru Teodor Iancu
Journal:  J Clin Med       Date:  2021-02-04       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.